ID   BT-16
AC   CVCL_M156
SY   BT 16; BT16
DR   cancercelllines; CVCL_M156
DR   Cell_Model_Passport; SIDM01521
DR   DepMap; ACH-001020
DR   PharmacoDB; BT16_119_2019
DR   Wikidata; Q54798449
RX   PubMed=17446062;
RX   PubMed=22206574;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Biegel, Jaclyn A.; Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
RX   PubMed=17446062; DOI=10.1016/j.ejca.2007.03.003;
RA   D'cunja, Jaya
RA   Shalaby, Tarek
RA   Rivera, Paola
RA   von Bueren, Andre O.
RA   Patti, Ratnakar
RA   Heppner, Frank L.
RA   Arcaro, Alexandre
RA   Rorke-Adams, Lucy Balian
RA   Phillips, Peter C.
RA   Grotzer, Michael A.
RT   "Antisense treatment of IGF-IR induces apoptosis and enhances
RT   chemosensitivity in central nervous system atypical teratoid/rhabdoid
RT   tumours cells.";
RL   Eur. J. Cancer 43:1581-1589(2007).
//
RX   PubMed=22206574; DOI=10.1186/1475-2867-11-44; PMCID=PMC3278350;
RA   Jayanthan, Aarthi A.
RA   Bernoux, Delphine
RA   Bose, Pinaki
RA   Riabowol, Karl Thomas
RA   Narendran, Aru
RT   "Multi-tyrosine kinase inhibitors in preclinical studies for pediatric
RT   CNS AT/RT: evidence for synergy with topoisomerase-I inhibition.";
RL   Cancer Cell Int. 11:44.1-44.11(2011).
//